Walgreens Boots Alliance (NASDAQ:WBA) Receives New Coverage from Analysts at Deutsche Bank

Deutsche Bank assumed coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA) in a report published on Thursday, Briefing.com Automated Import reports. The firm issued a sell rating on the pharmacy operator’s stock.

Other analysts have also issued reports about the company. Zacks Investment Research lowered Walgreens Boots Alliance from a hold rating to a sell rating and set a $53.00 price objective on the stock. in a research note on Monday, June 10th. BidaskClub raised Walgreens Boots Alliance from a strong sell rating to a sell rating in a research note on Wednesday. JPMorgan Chase & Co. lowered their price objective on Walgreens Boots Alliance from $74.00 to $73.00 and set an overweight rating for the company in a research report on Friday, June 28th. Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $61.00 to $58.00 and set an equal weight rating for the company in a research report on Friday, August 23rd. Finally, Bank of America lowered their target price on Walgreens Boots Alliance from $53.00 to $51.00 and set an underperform rating for the company in a report on Monday, June 3rd. Seven analysts have rated the stock with a sell rating, eleven have assigned a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of Hold and an average price target of $63.65.

NASDAQ:WBA traded up $0.36 during trading hours on Thursday, hitting $55.92. The company’s stock had a trading volume of 367,670 shares, compared to its average volume of 4,468,094. The stock has a fifty day simple moving average of $52.32 and a 200-day simple moving average of $55.15. The company has a market capitalization of $51.37 billion, a P/E ratio of 9.30, a PEG ratio of 1.42 and a beta of 0.88. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.76 and a quick ratio of 0.37. Walgreens Boots Alliance has a twelve month low of $49.03 and a twelve month high of $86.31.



Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Thursday, June 27th. The pharmacy operator reported $1.47 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.05. The business had revenue of $34.59 billion for the quarter, compared to analyst estimates of $34.52 billion. Walgreens Boots Alliance had a return on equity of 22.08% and a net margin of 3.53%. Walgreens Boots Alliance’s revenue was up .7% compared to the same quarter last year. During the same period last year, the firm posted $1.53 earnings per share. On average, equities analysts predict that Walgreens Boots Alliance will post 5.98 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, September 12th. Shareholders of record on Tuesday, August 20th were given a $0.458 dividend. The ex-dividend date of this dividend was Monday, August 19th. This represents a $1.83 annualized dividend and a yield of 3.28%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.44. Walgreens Boots Alliance’s payout ratio is currently 30.40%.

In other Walgreens Boots Alliance news, CAO Marco Patrick Anthony Pagni sold 215,323 shares of the business’s stock in a transaction on Wednesday, August 14th. The stock was sold at an average price of $50.48, for a total value of $10,869,505.04. Following the transaction, the chief accounting officer now owns 357,851 shares of the company’s stock, valued at $18,064,318.48. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 15.73% of the stock is currently owned by insiders.

A number of hedge funds have recently bought and sold shares of WBA. Caisse DE Depot ET Placement DU Quebec raised its stake in shares of Walgreens Boots Alliance by 11.0% during the 2nd quarter. Caisse DE Depot ET Placement DU Quebec now owns 11,837,465 shares of the pharmacy operator’s stock valued at $647,154,000 after purchasing an additional 1,169,600 shares during the period. LSV Asset Management raised its stake in shares of Walgreens Boots Alliance by 0.9% during the 1st quarter. LSV Asset Management now owns 11,672,531 shares of the pharmacy operator’s stock valued at $738,521,000 after purchasing an additional 107,600 shares during the period. Northern Trust Corp raised its stake in shares of Walgreens Boots Alliance by 0.7% during the 2nd quarter. Northern Trust Corp now owns 11,647,146 shares of the pharmacy operator’s stock valued at $636,750,000 after purchasing an additional 76,864 shares during the period. Geode Capital Management LLC raised its stake in shares of Walgreens Boots Alliance by 7.8% during the 4th quarter. Geode Capital Management LLC now owns 11,529,136 shares of the pharmacy operator’s stock valued at $786,522,000 after purchasing an additional 834,241 shares during the period. Finally, Nordea Investment Management AB raised its stake in shares of Walgreens Boots Alliance by 2.0% during the 1st quarter. Nordea Investment Management AB now owns 7,679,640 shares of the pharmacy operator’s stock valued at $485,896,000 after purchasing an additional 148,814 shares during the period. 59.80% of the stock is currently owned by institutional investors and hedge funds.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Further Reading: How interest rates affect municipal bond prices

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.